08/2017. Allergoid-mannan conjugates in veterinary medicine
A study on novel allergoid-glycoconjugates for the treatment of canine atopic dermatitis has been published in Veterinary Immunology Immunopathology.
This disease is caused by allergies and is treated with allergen vaccines. The novel glycoconjugates developed by INMUNOTEK are polymers of allergens coupled to nonoxidized mannan derived from Saccharomyces cerevisae. These glycoconjugates are best captured by dendritic cells (the cells of immune system that initiate an immune response) than conventional uncoupled allergens.
